Publication | Open Access

Cerebrospinal Fluid Concentration of Erlotinib and its Active Metabolite OSI-420 in Patients with Central Nervous System Metastases of Non-small Cell Lung Cancer

Cerebrospinal Fluid ConcentrationMedicineMetronomic TherapyPharmacologyActive Metabolite Osi-420Cancer TreatmentLung CancerOncologyRadiation OncologyTumor MicroenvironmentCancer Growth